{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:56:39Z","timestamp":1747230999505,"version":"3.40.5"},"reference-count":30,"publisher":"Medwave Estudios Limitada","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medwave"],"abstract":"<jats:p>Objective We aim to evaluate factors associated with the recurrence of thromboembolic episodes among patients with a first episode of venous thromboembolic disease during anticoagulation treatment and at least one year after treatment suspension.  Methods A prospective cohort of patients with a first episode of deep vein thrombosis confirmed by Doppler ultrasound and initiated anticoagulation treatment. Participants were registered in the Institutional Registry of Thromboembolic Disease between June 2015 and March 2019. Patients with cancer, with permanent inferior vena cava filter implant, and those who refused to participate or did not provide informed consent were excluded. All patients were evaluated within treatment at 30 days and at least one year after the suspension of anticoagulation with a D-dimer study and an ultrasound. All patients were evaluated for recurrence, bleeding (major and minor), and death.  Results A total of 304 patients were recruited during the study period. Seventy-three percent were female, and the median age was 80 years. The rate of recurrence rate during anticoagulation treatment was 5% (N = 16\/303; 95% confidence interval: 3 to 8), and 5% during post-suspension follow-up (N = 11\/202; 95%CI: 3 to 9). The overall bleeding rate was 13% (N = 39; 95%CI: 9 to 17), and 5% for major bleeding. Patients who recurred had higher basal D-dimer mean, higher neutrophils and monocytes, and a higher prevalence of age-adjusted D-dimer ratio greater than 0.5 before discontinuation. In addition, they more frequently had complete leg involvement by ultrasound and received a shorter treatment.  Conclusions Although some baseline and pre-suspension parameters had a higher recurrence incidence, statistical significance was not reached, probably due to small statistical power and a short-term follow-up.<\/jats:p>","DOI":"10.5867\/medwave.2021.11.002068","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T19:25:57Z","timestamp":1641324357000},"page":"e002068-e002068","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of recurrence of venous thromboembolic disease after discontinuing of anticoagulation: a prospective cohort study"],"prefix":"10.5867","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1403-7069","authenticated-orcid":false,"given":"Mar\u00eda Lourdes","family":"Posadas-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-7416","authenticated-orcid":false,"given":"Felipe","family":"Torres G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-6704","authenticated-orcid":false,"given":"Daniela","family":"Mezzarobba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-7186","authenticated-orcid":false,"given":"Natalia","family":"Schutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-4713","authenticated-orcid":false,"given":"Jesica","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-3755","authenticated-orcid":false,"given":"Fernanda","family":"Dovasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1281-7144","authenticated-orcid":false,"given":"Marta Elba","family":"Martinuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1480-5101","authenticated-orcid":false,"given":"Fernando Javier","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9052-6684","authenticated-orcid":false,"given":"Fernan","family":"de Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3888","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Acute Pulmonary Embolism. New England Journal of Medicine. 2010:1972-1975 | CrossRef |","DOI":"10.1056\/NEJMc1009061"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez FJ, Posadas-Mart\u00ednez ML, Vicens J, Gonz\u00e1lez Bernaldo de Quir\u00f3s F, Giunta DH. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J. 2013;11: 16. | CrossRef |","DOI":"10.1186\/1477-9560-11-16"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Galanaud J-P, Sevestre-Pietri M-A, Bosson J-L, Laroche J-P, Righini M, Brisot D, et al. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost. 2009;102: 493-500 | CrossRef |","DOI":"10.1160\/TH09-01-0053"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Heit JA, Lahr BD, Petterson TM, Bailey KR, Ashrani AA, Melton LJ 3rd. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood. 2011;118: 4992-4999. | CrossRef |","DOI":"10.1182\/blood-2011-05-357343"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Salvi A, Nitti C, Fabbri A, Groff P, Ruggiero EG, Agnelli G. Diagnosis and Treatment of Deep Vein Thrombosis in the Emergency Department: Results of an Italian Nominal Group Technique Study. Clin Appl Thromb Hemost. 2020;26. | CrossRef |","DOI":"10.1177\/1076029620959720"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Hirsh J, Lee AYY. How we diagnose and treat deep vein thrombosis. Blood. 2002;99: 3102-3110. | CrossRef |","DOI":"10.1182\/blood.V99.9.3102"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133: 454S-545S. | CrossRef |","DOI":"10.1378\/chest.08-0658"},{"key":"ref7","unstructured":"Yamaki T. Recent Advances in Hematology Research: Deep Vein Thrombosis: Symptoms, Diagnosis and Treatments. Nova Science Publishers; 2012."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147: 766-774. | CrossRef |","DOI":"10.7326\/0003-4819-147-11-200712040-00007"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Rose PE. Risk Factors for Venous Thromboembolism. Handbook of Venous Thromboembolism. Chichester, UK: John Wiley & Sons, Ltd; 2017:1-12.","DOI":"10.1002\/9781119095606.ch1"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Kyrle PA, Eichinger S. Risk assessment for recurrent venous thrombosis - Authors' reply. Lancet. 2011;377: 1073-1074. | CrossRef |","DOI":"10.1016\/S0140-6736(11)60427-3"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Poli D, Cenci C, Antonucci E, Grifoni E, Arcangeli C, Prisco D, et al. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy. Thromb Haemost. 2013;109: 181-186. | CrossRef |","DOI":"10.1160\/TH12-07-0534"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Kyrle PA, Eichinger S. The risk of recurrent venous thromboembolism: the Austrian Study on Recurrent Venous Thromboembolism. Wien Klin Wochenschr. 2003;115: 471-474. | CrossRef |","DOI":"10.1007\/BF03041030"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Piazza G, Goldhaber S, Kroll A, Goldberg R, Emery C, Spencer F. Venous thromboembolism in patients with diabetes mellitus. J Am Coll Cardiol. 2012;59: E1874. | CrossRef |","DOI":"10.1016\/S0735-1097(12)61875-0"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Galanaud J-P, Sevestre M-A, Genty C, Laroche J-P, Zizka V, Qu\u00e9r\u00e9 I, et al. Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis. J Vasc Surg. 2010;52: 932-8, 938.e1-2. | CrossRef |","DOI":"10.1016\/j.jvs.2010.05.019"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Akesson H, Brudin L, Dahlstr\u00f6m JA, Ekl\u00f6f B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990;4: 4348. | CrossRef |","DOI":"10.1016\/S0950-821X(05)80037-4"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020:m2177. | CrossRef |","DOI":"10.1136\/bmj.m2177"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Prandoni P, Lensing AWA, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137: 955-960. | CrossRef |","DOI":"10.7326\/0003-4819-137-12-200212170-00008"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost. 2002;87: 7-12. | CrossRef |","DOI":"10.1055\/s-0037-1612936"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Khan F, Rodger M. 4. Abstract title: Meta-analysis of long-term risk of recurrent venous thromboembolism after stopping anticoagulation in men and women with first unprovoked venous thromboembolism. Thromb Res. 2018;170: 5. | CrossRef |","DOI":"10.1016\/j.thromres.2018.09.028"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Nagler M, Ten Cate H, Prins MH, Ten Cate-Hoek AJ. Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction. Res Pract Thromb Haemost. 2018;2: 299-309. | CrossRef |","DOI":"10.1002\/rth2.12079"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Klein SJ, Vedantham S. Acute deep vein thrombosis cases in the real world. Semin Intervent Radiol. 2012;29: 23-28. | CrossRef |","DOI":"10.1055\/s-0032-1302448"},{"key":"ref22","unstructured":"Ioannou P, Kladou E. Anticoagulation management in deep venous thrombosis - real world data and unmet needs. Hippokratia. 2019;23: 144. | Link |"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Acute Pulmonary Embolism. New England Journal of Medicine. 2010:1972-1975. | CrossRef |","DOI":"10.1056\/NEJMc1009061"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica. 2007;92:1107-1114. | CrossRef |","DOI":"10.3324\/haematol.10234"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med. 2006;166: 729-736. | CrossRef |","DOI":"10.1001\/archinte.166.7.729"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133-1138. | CrossRef |","DOI":"10.1056\/NEJMoa035241"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007:199-205. | CrossRef |","DOI":"10.3324\/haematol.10516"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Labropoulos N, Waggoner T, Sammis W, Samali S, Pappas PJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg. 2008;48: 407-412. | CrossRef |","DOI":"10.1016\/j.jvs.2008.03.016"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Enr\u00edquez A, Baranchuk A, Corbal\u00e1n R. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies]. Rev Med Chil. 2019;147: 73-82. | CrossRef |","DOI":"10.4067\/S0034-98872019000100073"}],"container-title":["Medwave"],"original-title":["Predictores de recurrencia de enfermedad tromboemb\u00f3lica venosa post suspensi\u00f3n de anticoagulaci\u00f3n: estudio de cohorte prospectiva"],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T13:22:03Z","timestamp":1641820923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medwave.cl\/link.cgi\/Medwave\/Estudios\/Investigacion\/8504.act"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.5867\/medwave.2021.11.002068","relation":{},"ISSN":["0717-6384"],"issn-type":[{"type":"electronic","value":"0717-6384"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}